| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |